215 related articles for article (PubMed ID: 2461565)
1. Binding region for human immunodeficiency virus (HIV) and epitopes for HIV-blocking monoclonal antibodies of the CD4 molecule defined by site-directed mutagenesis.
Mizukami T; Fuerst TR; Berger EA; Moss B
Proc Natl Acad Sci U S A; 1988 Dec; 85(23):9273-7. PubMed ID: 2461565
[TBL] [Abstract][Full Text] [Related]
2. A soluble recombinant polypeptide comprising the amino-terminal half of the extracellular region of the CD4 molecule contains an active binding site for human immunodeficiency virus.
Berger EA; Fuerst TR; Moss B
Proc Natl Acad Sci U S A; 1988 Apr; 85(7):2357-61. PubMed ID: 2451247
[TBL] [Abstract][Full Text] [Related]
3. Epitope mapping of the human immunodeficiency virus type 1 gp120 with monoclonal antibodies.
Dowbenko D; Nakamura G; Fennie C; Shimasaki C; Riddle L; Harris R; Gregory T; Lasky L
J Virol; 1988 Dec; 62(12):4703-11. PubMed ID: 2460639
[TBL] [Abstract][Full Text] [Related]
4. Structural analysis of the human immunodeficiency virus-binding domain of CD4. Epitope mapping with site-directed mutants and anti-idiotypes.
Sattentau QJ; Arthos J; Deen K; Hanna N; Healey D; Beverley PC; Sweet R; Truneh A
J Exp Med; 1989 Oct; 170(4):1319-34. PubMed ID: 2477490
[TBL] [Abstract][Full Text] [Related]
5. Effects of anti-gp120 monoclonal antibodies on CD4 receptor binding by the env protein of human immunodeficiency virus type 1.
Linsley PS; Ledbetter JA; Kinney-Thomas E; Hu SL
J Virol; 1988 Oct; 62(10):3695-702. PubMed ID: 2458487
[TBL] [Abstract][Full Text] [Related]
6. CD4 molecules with a diversity of mutations encompassing the CDR3 region efficiently support human immunodeficiency virus type 1 envelope glycoprotein-mediated cell fusion.
Broder CC; Berger EA
J Virol; 1993 Feb; 67(2):913-26. PubMed ID: 8419649
[TBL] [Abstract][Full Text] [Related]
7. Binding of the human retrovirus HTLV-III/LAV/ARV/HIV to the CD4 (T4) molecule: conformation dependence, epitope mapping, antibody inhibition, and potential for idiotypic mimicry.
McDougal JS; Nicholson JK; Cross GD; Cort SP; Kennedy MS; Mawle AC
J Immunol; 1986 Nov; 137(9):2937-44. PubMed ID: 2428879
[TBL] [Abstract][Full Text] [Related]
8. Generation and characterization of monoclonal antibodies to the putative CD4-binding domain of human immunodeficiency virus type 1 gp120.
Sun NC; Ho DD; Sun CR; Liou RS; Gordon W; Fung MS; Li XL; Ting RC; Lee TH; Chang NT
J Virol; 1989 Sep; 63(9):3579-85. PubMed ID: 2474670
[TBL] [Abstract][Full Text] [Related]
9. An immune-selected point mutation in the transmembrane protein of human immunodeficiency virus type 1 (HXB2-Env:Ala 582(-->Thr)) decreases viral neutralization by monoclonal antibodies to the CD4-binding site.
Klasse PJ; McKeating JA; Schutten M; Reitz MS; Robert-Guroff M
Virology; 1993 Sep; 196(1):332-7. PubMed ID: 8356803
[TBL] [Abstract][Full Text] [Related]
10. Functional mimicry of a human immunodeficiency virus type 1 coreceptor by a neutralizing monoclonal antibody.
Xiang SH; Farzan M; Si Z; Madani N; Wang L; Rosenberg E; Robinson J; Sodroski J
J Virol; 2005 May; 79(10):6068-77. PubMed ID: 15857992
[TBL] [Abstract][Full Text] [Related]
11. Genetic analysis of monoclonal antibody and HIV binding sites on the human lymphocyte antigen CD4.
Peterson A; Seed B
Cell; 1988 Jul; 54(1):65-72. PubMed ID: 2454749
[TBL] [Abstract][Full Text] [Related]
12. The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4.
Landau NR; Warton M; Littman DR
Nature; 1988 Jul; 334(6178):159-62. PubMed ID: 3260352
[TBL] [Abstract][Full Text] [Related]
13. A potent, neutralizing human monoclonal antibody against a unique epitope overlapping the CD4-binding site of HIV-1 gp120 that is broadly conserved across North American and African virus isolates.
Pinter A; Honnen WJ; Racho ME; Tilley SA
AIDS Res Hum Retroviruses; 1993 Oct; 9(10):985-96. PubMed ID: 7506556
[TBL] [Abstract][Full Text] [Related]
14. Mapping the CD4 binding site for human immunodeficiency virus by alanine-scanning mutagenesis.
Ashkenazi A; Presta LG; Marsters SA; Camerato TR; Rosenthal KA; Fendly BM; Capon DJ
Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7150-4. PubMed ID: 2402498
[TBL] [Abstract][Full Text] [Related]
15. Expression and functional activity of isotype and subclass switched human monoclonal antibody reactive with the base of the V3 loop of HIV-1 gp120.
Liu F; Bergami PL; Duval M; Kuhrt D; Posner M; Cavacini L
AIDS Res Hum Retroviruses; 2003 Jul; 19(7):597-607. PubMed ID: 12908937
[TBL] [Abstract][Full Text] [Related]
16. Binding of antibodies to virion-associated gp120 molecules of primary-like human immunodeficiency virus type 1 (HIV-1) isolates: effect on HIV-1 infection of macrophages and peripheral blood mononuclear cells.
Stamatatos L; Zolla-Pazner S; Gorny MK; Cheng-Mayer C
Virology; 1997 Mar; 229(2):360-9. PubMed ID: 9126249
[TBL] [Abstract][Full Text] [Related]
17. The effect of low-profile serine substitutions in the V3 loop of HIV-1 gp120 IIIB/LAI on the immunogenicity of the envelope protein.
Peet NM; McKeating JA; de Souza JB; Roitt IM; Delves PJ; Lund T
Virology; 1998 Nov; 251(1):59-70. PubMed ID: 9813203
[TBL] [Abstract][Full Text] [Related]
18. Unique binding modes for the broad neutralizing activity of single-chain variable fragments (scFv) targeting CD4-induced epitopes.
Tanaka K; Kuwata T; Alam M; Kaplan G; Takahama S; Valdez KPR; Roitburd-Berman A; Gershoni JM; Matsushita S
Retrovirology; 2017 Sep; 14(1):44. PubMed ID: 28938888
[TBL] [Abstract][Full Text] [Related]
19. Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein.
Jameson BA; Rao PE; Kong LI; Hahn BH; Shaw GM; Hood LE; Kent SB
Science; 1988 Jun; 240(4857):1335-9. PubMed ID: 2453925
[TBL] [Abstract][Full Text] [Related]
20. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with the CD4 receptor.
Lasky LA; Nakamura G; Smith DH; Fennie C; Shimasaki C; Patzer E; Berman P; Gregory T; Capon DJ
Cell; 1987 Sep; 50(6):975-85. PubMed ID: 2441877
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
